Overview

Al18F-NOTA-LM3 PET/CT in Patients With TIO

Status:
RECRUITING
Trial end date:
2026-05-30
Target enrollment:
Participant gender:
Summary
This is a pilot study to assess the value of whole-body Al18F-NOTA-LM3 PET/CT in patients with tumor-induced osteomalacia.
Phase:
NA
Details
Lead Sponsor:
Peking Union Medical College Hospital